Circulating tumor cells can provide 'real-time' information on patient's current disease state

Circulating tumor cells (CTCs) may be a promising alternative, noninvasive source of tumor materials for biomarker assessment, according to data presented at the Fourth AACR International Conference on Molecular Diagnostics in Cancer Therapeutic Development.

Read the whole article on Physorg

More from Physorg